- Home
- CBL vs CRMD Comparison
CBL vs CRMD Comparison
Compare CBL & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBL
- CRMD
- Stock Information
- Founded
- CBL 1978
- CRMD 2006
- Country
- CBL United States
- CRMD United States
- Employees
- CBL N/A
- CRMD N/A
- Industry
- CBL Real Estate Investment Trusts
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- CBL Real Estate
- CRMD Health Care
- Exchange
- CBL Nasdaq
- CRMD Nasdaq
- Market Cap
- CBL 777.7M
- CRMD 901.8M
- IPO Year
- CBL 1993
- CRMD 2010
- Fundamental
- Price
- CBL $30.39
- CRMD $12.93
- Analyst Decision
- CBL
- CRMD Strong Buy
- Analyst Count
- CBL 0
- CRMD 7
- Target Price
- CBL N/A
- CRMD $16.83
- AVG Volume (30 Days)
- CBL 144.4K
- CRMD 3.3M
- Earning Date
- CBL 08-06-2025
- CRMD 08-07-2025
- Dividend Yield
- CBL 5.92%
- CRMD N/A
- EPS Growth
- CBL 128.05
- CRMD N/A
- EPS
- CBL 2.10
- CRMD 0.79
- Revenue
- CBL $539,452,000.00
- CRMD $121,484,498.00
- Revenue This Year
- CBL N/A
- CRMD $278.96
- Revenue Next Year
- CBL N/A
- CRMD $45.85
- P/E Ratio
- CBL $14.49
- CRMD $16.34
- Revenue Growth
- CBL 2.20
- CRMD 14970.29
- 52 Week Low
- CBL $21.10
- CRMD $4.67
- 52 Week High
- CBL $33.54
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- CBL 75.94
- CRMD 60.17
- Support Level
- CBL $29.66
- CRMD $9.61
- Resistance Level
- CBL $30.33
- CRMD $12.09
- Average True Range (ATR)
- CBL 0.60
- CRMD 0.83
- MACD
- CBL 0.27
- CRMD 0.19
- Stochastic Oscillator
- CBL 98.88
- CRMD 98.81
About CBL CBL & Associates Properties Inc.
CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.